Селваковатеин

Rec. INN (наименование, зарегистрированное ВОЗ)

2750241-84-8

severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), beta lineage (B.1.351) spike (S) glycoprotein (natural variant K⁴⁰⁴>N⁹⁹, E⁴⁷¹>K¹⁶⁶, N⁴⁸⁸>Y¹⁸³) receptor binding domain (RBD) fragment (306-524, 1-219 in the current sequence), fused to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), alpha lineage (B.1.1.7) spike (S) glycoprotein (natural variant N⁴⁸⁸>Y⁴⁰²), receptor binding domain (RBD) fragment (306-524, 220-438 in the current sequence), produced in Chinese hamster ovary (CHO)-K1 cells, glycoform alfa

Поделиться этой страницей